Comparison of ACT Between Hemochron Jr and ACT Plus
Primary Purpose
Cardiac Disease
Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Hemochron
ACT Plus
Sponsored by

About this trial
This is an interventional diagnostic trial for Cardiac Disease focused on measuring Whole Blood Coagulation Time, cardiac surgery
Eligibility Criteria
Inclusion Criteria:
- Patients who underwent cardiac surgery with heparin administration.
Exclusion Criteria:
- Preoperative hemoglobin under 11g/dL
- Weight under 40kg
- Preoperative coagulopathy
Sites / Locations
- Hallym University Sacred Heart Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Patient
Arm Description
Patients were checked activated coagulation time by both Hemochron Jr and ACT Plus during cardiac surgery with heparin administration.
Outcomes
Primary Outcome Measures
Comparison of activated coagulation time between Hemochron Jr and ACT Plus
Secondary Outcome Measures
Full Information
NCT ID
NCT02484157
First Posted
June 25, 2015
Last Updated
June 26, 2015
Sponsor
Hallym University Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT02484157
Brief Title
Comparison of ACT Between Hemochron Jr and ACT Plus
Official Title
Comparison of Activated Coagulation Time Between Hemochron Jr and ACT Plus During Cardiac Surgery for Patient Using Acute Normovolemic Hemodilution
Study Type
Interventional
2. Study Status
Record Verification Date
December 2012
Overall Recruitment Status
Completed
Study Start Date
December 2012 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
January 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hallym University Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study aimed to compare 2 activated clotting time analysers (Hemochron Jr vs. ACT Plus).
Detailed Description
Measurement of activated clotting time (ACT) is a standard method for anticoagulation monitoring. Especially in cardiac surgery, heparin is usually used as anticoagulant and protamine is used to reverse anticoagulation effect at the end of surgery. ACT method defines the time until a clot is formed in a test tube after triggering of internal pathway coagulation using blood activating agents (eg. kaolin).
Acute normovolemic hemodilution (ANH) consists of withdrawing patient's blood volume early in the operative period and concurrent infusion of crystalloid or colloid to maintain intravascular volume, and is used in cardiac surgery. ANH is known to affect hemostasis in some studies.
Assuming that accurate monitoring of coagulation therapy is important to prevent both thrombotic and hemorrhagic complications, we compared ACT results from 2 analysers (Hemochron Jr and ACT Plus) in patients undergoing cardiac surgery using ANH.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiac Disease
Keywords
Whole Blood Coagulation Time, cardiac surgery
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
Participant
Allocation
N/A
Enrollment
26 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patient
Arm Type
Experimental
Arm Description
Patients were checked activated coagulation time by both Hemochron Jr and ACT Plus during cardiac surgery with heparin administration.
Intervention Type
Device
Intervention Name(s)
Hemochron
Intervention Description
Activated coagulation time was checked serially by Hemochron Jr.
Intervention Type
Device
Intervention Name(s)
ACT Plus
Intervention Description
Activated coagulation time was checked serially by ACT Plus.
Primary Outcome Measure Information:
Title
Comparison of activated coagulation time between Hemochron Jr and ACT Plus
Time Frame
During cardiac surgeris (within 8 hours)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients who underwent cardiac surgery with heparin administration.
Exclusion Criteria:
Preoperative hemoglobin under 11g/dL
Weight under 40kg
Preoperative coagulopathy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Soo Kyung Lee, MD
Organizational Affiliation
Hallym University Medical Center
Official's Role
Study Chair
Facility Information:
Facility Name
Hallym University Sacred Heart Hospital
City
Anyang-si
State/Province
Gyeonggi-do
ZIP/Postal Code
KS009
Country
Korea, Republic of
12. IPD Sharing Statement
Citations:
PubMed Identifier
15506033
Citation
Svenmarker S, Appelblad M, Jansson E, Haggmark S. Measurement of the activated clotting time during cardiopulmonary bypass: differences between Hemotec ACT and Hemochron Jr apparatus. Perfusion. 2004;19(5):289-94. doi: 10.1191/0267659104pf755oa.
Results Reference
background
PubMed Identifier
19277416
Citation
Chia S, Van Cott EM, Raffel OC, Jang IK. Comparison of activated clotting times obtained using Hemochron and Medtronic analysers in patients receiving anti-thrombin therapy during cardiac catheterisation. Thromb Haemost. 2009 Mar;101(3):535-40.
Results Reference
background
PubMed Identifier
22534410
Citation
Bosch YP, Weerwind PW, Nelemans PJ, Maessen JG, Mochtar B. An evaluation of factors affecting activated coagulation time. J Cardiothorac Vasc Anesth. 2012 Aug;26(4):563-8. doi: 10.1053/j.jvca.2012.03.011. Epub 2012 Apr 24.
Results Reference
background
PubMed Identifier
16548858
Citation
Dalbert S, Ganter MT, Furrer L, Klaghofer R, Zollinger A, Hofer CK. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices. Acta Anaesthesiol Scand. 2006 Apr;50(4):461-8. doi: 10.1111/j.1399-6576.2006.00990.x.
Results Reference
background
Learn more about this trial
Comparison of ACT Between Hemochron Jr and ACT Plus
We'll reach out to this number within 24 hrs